Dyne Therapeutics develops therapeutics aimed at improving the functional outcomes for individuals with genetically driven neuromuscular diseases. By focusing on muscle and central nervous system interventions, the company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), along with preclinical initiatives for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease.
No jobs found
Try different keywords or remove some filters.
Or create a free account and we’ll email you when new jobs match what you’re looking for.
Create a free account
Searching
Want job alerts that match your preferences?
Set up job preferences →